NCI exceeds employment ceilings, must cut personnel in FY 2004, NIH says. Further cuts expected in extramural grant support staff.
Also ASCO to release abstracts to members prior to annual meeting.
Advisors suggest NCI establish sarcoma research consortium.
Lung cancer screening trial reaches accrual goal of 50,000.
Markison leaving Bristol-Myers, two others promoted in reorganization.
Wilding named director, Univ. of Wisconsin Cancer Center.
NABCO to close June 30.
This month’s 8-page Business & Regulatory Report included in this issue.
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Break Through Cancer’s Tyler Jacks: “We’ve created a new operating model for collaborative cancer research.”
- One result, two reactions: GRAIL’s Hall and NCI’s Castle react to negative NHS-Galleri trial outcome
- Vinay Prasad, oncology’s gadfly-turned-CBER-director, will leave FDA (again)
- GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis - As more people are surviving cancer, we must continue funding bold science









